Full name
DOPHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
47.73.Z - Retail sale of pharmaceutical products
49.41.Z - Road freight transport
52.10.B - Warehousing and storage of other goods
52.21.Z - Support activities for land transport
82.11.Z - Office administrative support activities and other business support services
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -1,4 | 1,7 | 2,5 | 48,6 |
Gross profit (loss) | -1,6 | 1,5 | 2,5 | 63 |
EBITDA | -1,3 | 1,9 | 2,9 | 53 |
Short time liabilities | 13,3 | 14,8 | 14,1 | -4,8 |
Other operating costs | 0,1 | 0 | 0 | -85,2 |
Equity capital | -2,3 | 2,1 | 4 | 92,5 |
Operating profit (EBIT) | -1,4 | 1,7 | 2,6 | 55,8 |
Assets | 12,6 | 19,6 | 21,2 | 8,1 |
Net profit (loss) | -2,3 | 1,2 | 1,9 | 62,4 |
Cash | 3,8 | 1,3 | 1 | -18,8 |
Net income from sale | 33,3 | 43,6 | 66,5 | 52,5 |
Liabilities and provisions for liabilities | 14,9 | 17,5 | 17,2 | -2 |
Working assets | 12,6 | 17,7 | 18,3 | 3,8 |
Other income costs | 0,1 | 0 | 0,1 | 386,9 |
Depreciation | 0,1 | 0,2 | 0,3 | 30,4 |
% | % | % | p.p. | |
Profitability of capital | 100,2 | 56,9 | 48 | -8,9 |
Equity capital to total assets | -17,9 | 10,7 | 19,1 | 8,4 |
Gross profit margin | -4,8 | 3,5 | 3,7 | 0,2 |
EBITDA Margin | -4 | 4,3 | 4,3 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 146 | 124 | 77 | -47 |
Current financial liquidity indicator | 0.9481650590896606 | 1.1961034536361694 | 1.3034698963165283 | 0,1 |
Net dept to EBITDA | 2.2122080326080322 | -0.27515774965286255 | -0.05076455697417259 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane